JNM CE/SAM (May 2018):Update on 18F-Fluciclovine PET for Prostate Cancer Imaging

JNM, May 2018, Volume 59, Number 5

Release Date: 5/1/2018
Expiration Date: 5/31/2021

SNMMI Members: Free
Non-Members: $69.00

Continuing Education Credit Information

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives
On successful completion of this activity, participants should be able to describe…
1.Clinical indications for fluciclovine PET and accuracy for local and metastatic disease.
2. Fluciclovine PET imaging protocol optimization.
3. Correct interpretation of local and metastatic disease and benign physiologic variants.

Target Audience
This article contains information of value to radiologists and nuclear medicine physicians, as well as to nuclear medicine technologists.

Author
Ephraim E. Parent and David M. Schuster
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia

Disclosure
The authors receive support from R01CA129356, R01CA121320, P50CA128301, 01CA204254, R01CA169188, RO1CA156755, R21CA176684, and U01CA113913, as well as from the Emory Winship Comprehensive Cancer Center and the Glenn Family Breast Center. Emory University is eligible to receive royalties from 18F-fluciclovine. Ephraim E. Parent and David M. Schuster have participated in sponsored research involving 18F-fluciclovine through the Emory University Office of Sponsored Projects, including funding from Blue Earth Diagnostics, Ltd., and Nihon Medi-Physics Co., Ltd. In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Contact Information

For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.